Skip to main content

Table 2 Hepatobiliary scintigraphy measurements at baseline and 3-month follow-up

From: Hepatobiliary scintigraphy may improve radioembolization treatment planning in HCC patients

  

Baseline

3-month follow-up

Case

 

Liver (total)

Liver (treated)

Liver (non-treated)

Liver (total)

Liver (treated)

Liver (non-treated)

1

Volume

2481

1845

636

1919

1357

562

%

100

74

26

100

71

29

cMUR

3.0

2.3

0.7

2.4

1.6

0.8

%

100

77

23

100

67

33

2

Volume

1396

1178

285

1111

855

256

%

100

84

16

100

77

23

cMUR

1.8

1.6

0.2

0.6

0.4

0.2

%

100

87

13

100

77

23

3

Volume

1288

881

407

1218

713

505

%

100

68

32

100

59

41

cMUR

2.2

1.5

0.7

1.8

0.8

1.0

%

100

70

30

100

43

57

  1. Volume (in mL); cMUR = BSA corrected 99mTc-mebrofenin uptake rate (in %/min/m2)